| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G |
| 12 Nov 2026 | PROSPECTUS |
| 10 Nov 2026 | FREE WRITING PROSPECTUS |
| 10 Nov 2026 | PROSPECTUS |
| 09 Nov 2026 | REGISTRATION STATEMENT |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
BREA, Calif., November 4, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended October 2, 2026. |
| 02 Nov 2026 |
Form 4: Keel Paul A, Director
Gave up 54,197 shares to cover exercise price or tax ($1.27M) |
| 27 Oct 2026 |
8-K: Regulation FD Disclosure
BREA, Calif., October 27, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced the publication of its 2025 Sustainability Report. The report provides an update on Envista’s progress in expanding acce... |
| 17 Sep 2026 |
8-K: Regulation FD Disclosure
On September 17, 2026, Envista Holdings Corporation (the "Company") will host its 2026 Investor Day, during which members of the Company's executive leadership team will provide an overview of the Company's strategy, growth initiatives, ... |
| 27 Aug 2026 |
Form 4: Acurio Veronica, President, Orthodontics
Gave up 7,710 shares to cover exercise price or tax ($212K) |
| 27 Aug 2026 |
Form 4: Befidi Robert, President, Diagnostics
Gave up 5,147 shares to cover exercise price or tax ($141K) |
| 27 Aug 2026 |
Form 4: Hammes Eric D., Chief Financial Officer
Gave up 10,885 shares to cover exercise price or tax ($299K) |
| 27 Aug 2026 |
Form 4: Nilsson Stefan, President, Nobel Biocare
Gave up 804 shares to cover exercise price or tax ($22.1K) |
| 24 Aug 2026 |
Form 4: Reis Mischa, SVP, Strategy & Bus. Dev.
Sold 8,000 shares ($220K) |
| 20 Aug 2026 |
Form 4: Keel Paul A, Director
Received 179,730 shares as a grant or award · Granted 159,900 Performance Share Unit |
| 20 Aug 2026 |
Form 4: Hammes Eric D., Chief Financial Officer
Granted 47,970 Performance Share Unit |
| 20 Aug 2026 | 144 |
| 19 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
Reference is made to the information contained in Item 8.01 of this Current Report on Form 8-K, disclosing the Company’s Board of Directors’ appointment of Paul Keel, the Company’s President and Chief Executive Officer, to the role of Ch... |
| 13 Aug 2026 |
Form 3: Thomas Coree K., CAO
Holds 5,814 shares of Common Stock |
Loading...